Market Size of United Kingdom Computed Tomography Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Market Size (2024) | USD 467.43 Million |
Market Size (2029) | USD 635.32 Million |
CAGR (2024 - 2029) | 6.33 % |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
UK Computed Tomography Market Analysis
The United Kingdom Computed Tomography Market size is estimated at USD 467.43 million in 2024, and is expected to reach USD 635.32 million by 2029, growing at a CAGR of 6.33% during the forecast period (2024-2029).
The COVID pandemic had an adverse effect on market growth. Various research studies have been published to provide insight into the effects of the pandemic. For instance, the COVID-19 pandemic: impact on NHS England PET-CT services and lessons learned is the title of a study that was conducted to determine how the first wave of COVID-19 affected the National Health Service's (NHS) 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT) scanning activity in England. The study was published in Nuclear Medicine Communication in February 2021. The analysis found that for the two months of April and May 2020, there was a 32 percent and a 31 percent decline in activity, respectively. Comparing cancer FDG PET-CT cases to non-cancer CT cases, a greater decline was seen. Between January 2020 and June 2020, 50,879 FDG PET-CTs were finished, compared to 52,460 FDG PET-CTs finished during the same time in 2019. Along with its negative effects, COVID-19 has given players the chance to build their presence by releasing new products or advancing clinical research in this area. Due to which, the studied market is expected to recover in future years.
The UK computed tomography market is majorly driven by higher incidences and mortality rates associated with chronic diseases, such as diabetes and cancer. The country's market is also driven by the growing geriatric population, increasing research and development procedures, rising investments, and increasing product launches. According to Globocan 2020, there were 457,960 new cases of cancer in the UK in 2020, and 595,909 instances are anticipated by 2040. The country will employ more CT scanners as a result of the anticipated rise in cancer cases because CT scanners are used to diagnose a variety of cancers. As a result, it is anticipated that the market under study will expand significantly during the next years. Another significant contributing factor to mortality in the nation is diabetes. The country has 5.6 percent prevalence of diabetes, with 2,680,500 people living with the disease, according to the International Diabetes Federation. Due to the fact that diabetes is the primary risk factor for many chronic illnesses, including cancer, this is anticipated to spur market expansion throughout the forecasted period. According to figures provided by the Organization for Economic Co-operation and Development, there were 9 CT scanners per 1,000,000 people in hospitals in the United Kingdom. Due to the growing burden of chronic diseases and the ageing population, more CT scanners are anticipated to be installed across the nation. This is anticipated to stimulate market expansion. Additionally, the National Research Facility (NRF) in Lab-based X-ray Computed Tomography was established in November 2020 with the help of the current facilities from the Universities of Manchester, Southampton, University College London (UCL), University of Warwick, and Diamond Light Source to offer the United Kingdom a special and varied shared capability. The Engineering and Physical Sciences Research Council (EPSRC) provided 10 million euros over 5 years to NRF to build this facility. Therefore, it is anticipated that rising product launches and rising investments in the relevant industry will fuel market expansion.
However, it is anticipated that the market expansion in the United Kindgom will be constrained by the inadequate reimbursement and the high cost of equipment and CT scan procedures.
UK Computed Tomography Industry Segmentation
As per the scope of the report, computed tomography (CT) is an imaging process that customizes special X-ray equipment to generate a sequence of exhaustive images or scans of areas inside the body. It is also called computerized axial tomography (CAT) scanning, primarily used in cancer diagnosis. The United Kingdom Computed Tomography Market is segmented by Type (Low Slice, Medium Slice, and High Slice), Application (Oncology, Neurology, Cardiovascular, Musculoskeletal, and Other Applications), and End User (Hospitals, Diagnostic Centers, and Other End Users). The report offers the value (in USD million) for the above segments.
By Type | |
Low Slice | |
Medium Slice | |
High Slice |
By Application | |
Oncology | |
Neurology | |
Cardiovascular | |
Musculoskeletal | |
Other Applications |
By End User | |
Hospitals | |
Diagnostic Centers | |
Other End Users |
United Kingdom Computed Tomography Market Size Summary
The United Kingdom computed tomography market is poised for significant growth over the forecast period, driven by an increasing prevalence of chronic diseases such as diabetes and cancer, alongside a growing geriatric population. The market is also bolstered by advancements in research and development, rising investments, and a surge in product launches. The anticipated rise in cancer cases is expected to lead to a higher demand for CT scanners, which are crucial for diagnosing various cancers. This demand is further supported by government initiatives and investments aimed at enhancing healthcare infrastructure, such as the establishment of new diagnostic centers and the distribution of mobile CT scanners. Despite the challenges posed by high equipment costs and inadequate reimbursement, the market is expected to expand due to the high prevalence of cancer and the presence of key market players.
The competitive landscape of the UK computed tomography market is moderately active, with several major players like Canon Medical Systems, GE Healthcare, and Koninklijke Philips NV leading the charge. These companies are actively involved in expanding their capabilities and enhancing their product offerings to meet the growing demand. Government investments, such as the funding for new CT scanners and the establishment of research facilities, are expected to further stimulate market growth. Additionally, the market is anticipated to benefit from the increasing number of cancer screening programs and the ongoing efforts to address healthcare backlogs, which will drive the demand for computed tomography devices. Overall, the market is set to recover and grow, leveraging both technological advancements and strategic investments.
United Kingdom Computed Tomography Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Prevalence of Chronic Diseases
-
1.2.2 Rising Geriatric Population
-
1.2.3 Increasing Technological Advancements
-
-
1.3 Market Restraints
-
1.3.1 Lack Of Proper Reimbursement And Stringent Regulatory Approval Procedures
-
1.3.2 High Cost of Equipment
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Type
-
2.1.1 Low Slice
-
2.1.2 Medium Slice
-
2.1.3 High Slice
-
-
2.2 By Application
-
2.2.1 Oncology
-
2.2.2 Neurology
-
2.2.3 Cardiovascular
-
2.2.4 Musculoskeletal
-
2.2.5 Other Applications
-
-
2.3 By End User
-
2.3.1 Hospitals
-
2.3.2 Diagnostic Centers
-
2.3.3 Other End Users
-
-
United Kingdom Computed Tomography Market Size FAQs
How big is the United Kingdom Computed Tomography Market?
The United Kingdom Computed Tomography Market size is expected to reach USD 467.43 million in 2024 and grow at a CAGR of 6.33% to reach USD 635.32 million by 2029.
What is the current United Kingdom Computed Tomography Market size?
In 2024, the United Kingdom Computed Tomography Market size is expected to reach USD 467.43 million.